NCI | Technology Transfer

TLT-1, A Novel Platelet-Associated Receptor and Uses Therefor

Read more about TLT-1, A Novel Platelet-Associated Receptor and Uses Therefor

US Application 10/802,441
Filed on 2004-03-16

THERAPEUTIC USES OF HMGN1 AND HMGN2

Read more about THERAPEUTIC USES OF HMGN1 AND HMGN2

Patent Cooperation Treaty
PCT/US2004/08060
Filed on 2004-03-17

Enhanced HIV-1 Vaccines and Methods for Their Use

Read more about Enhanced HIV-1 Vaccines and Methods for Their Use

Patent Cooperation Treaty
PCT/US2004/09617
Filed on 2004-03-29

Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)

Read more about Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)

Ireland
98948429.0
Filed on 1998-09-22

Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)

Read more about Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)

Belgium
98948429.0
Filed on 1998-09-22

Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)

Read more about Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)

Switzerland
98948429.0
Filed on 1998-09-22

Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)

Read more about Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)

Spain
98948429.0
Filed on 1998-09-22

Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)

Read more about Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)

Italy
98948429.0
Filed on 1998-09-22

Agonist and Antagonist Petide of Carcinoembryonic Antigen (CEA)

Read more about Agonist and Antagonist Petide of Carcinoembryonic Antigen (CEA)

United Kingdom
98948429.0
Filed on 1998-09-22

Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)

Read more about Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)

France
98948429.0
Filed on 1998-09-22

Subscribe to NCI